Isan Chen
2013
In 2013, Isan Chen earned a total compensation of $1.8M as Executive Vice President and Chief Medical and Development Officer at Mirati Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $45,000 |
|---|---|
| Option Awards | $1,693,172 |
| Salary | $106,731 |
| Other | $2,819 |
| Total | $1,847,722 |
Chen received $1.7M in option awards, accounting for 92% of the total pay in 2013.
Chen also received $45K in non-equity incentive plan, $106.7K in salary and $2.8K in other compensation.
Rankings
In 2013, Isan Chen's compensation ranked 4,162nd out of 12,286 executives tracked by ExecPay. In other words, Chen earned more than 66.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,162 out of 12,286 | 66th |
Division Manufacturing | 1,425 out of 4,612 | 69th |
Major group Chemicals And Allied Products | 387 out of 1,462 | 74th |
Industry group Drugs | 268 out of 1,156 | 77th |
Industry Pharmaceutical Preparations | 218 out of 890 | 76th |
Source: SEC filing on April 17, 2014.
Chen's colleagues
We found two more compensation records of executives who worked with Isan Chen at Mirati Therapeutics in 2013.